SSY Group Limited (HKG:2005)

Market Cap	7.28B -22.3%
Revenue (ttm)	4.58B -29.2%
Net Income	658.92M -51.8%
EPS	0.22 -51.4%
Shares Out	2.90B
PE Ratio	11.25
Forward PE	11.69
Dividend	0.15 (5.78%)
Ex-Dividend Date	Sep 11, 2025

Volume	82,871,030
Average Volume	14,465,758
Open	2.370
Previous Close	2.360
Day's Range	2.360 - 2.510
52-Week Range	2.360 - 3.500
Beta	0.49
RSI	33.22
Earnings Date	Mar 27, 2026

About SSY Group

SSY Group Limited, an investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC and upright soft bag, PP plastic bottle, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, Chinese medicine preparations, and biological preparations, as well as bulk pharmaceuti...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1999
• Employees: 5,700
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2005

Financial Performance

In 2024, SSY Group's revenue was 5.77 billion, a decrease of -10.67% compared to the previous year's 6.46 billion. Earnings were 1.06 billion, a decrease of -19.53%.